Literature DB >> 1793463

Technetium-99m HMPAO labeled leukocytes in inflammation imaging.

K Uno1, K Yoshikawa, K Imazeki, S Minoshima, N Arimizu.   

Abstract

Technetium-99m-HMPAO (Tc-99m-HMPAO) labeled leukocyte imaging was carried out in 19 patients at 3-5 hr after reinjection. There were no side effects noted. Tc-99m leukocyte images showed gall bladder, colon, kidney, and urinary bladder activity in normal distribution as a result of excretion of the eluted Tc-99m complex. They yielded a sensitivity of 93%, a specificity of 100% and an accuracy of 95%. They were correctly positive in 14 out of 19 cases. But one false negative case was seen in a patient with pyonephrosis showing a lack of renal function with decreased renal blood flow. It was concluded that they have some advantages over In-111 leukocyte images, but we have to consider the fact that the ureteral obstruction or the lack of renal function with decreased renal blood flow may result in a false positive or a false negative case.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1793463     DOI: 10.1007/bf03164618

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  17 in total

1.  [Indium-111 labeled leukocytes for an inflammatory scintigraphy].

Authors:  K Uno; K Imazeki; N Arimizu
Journal:  Rinsho Hoshasen       Date:  1988-02

2.  [Clinical usage of indium-111 labeled leukocyte scintigraphy and technetium-99m methylene diphosphonate scintigraphy in patients with total hip replacement].

Authors:  T Terauchi; K Uno; T Yuyama; K Seto; N Arimizu; T Suguro; H Moriya; S Uematsu
Journal:  Kaku Igaku       Date:  1988-10

3.  Inflammation: imaging with Tc-99m HMPAO-labeled leukocytes.

Authors:  M E Roddie; A M Peters; H J Danpure; S Osman; B L Henderson; J P Lavender; M J Carroll; R D Neirinckx; J D Kelly
Journal:  Radiology       Date:  1988-03       Impact factor: 11.105

4.  In vitro comparison of HMPAO and gentisic acid for labelling leukocytes with 99mTc.

Authors:  M Ecclestone; A Proulx; J R Ballinger; B Gerson; R H Reid; K Y Gulenchyn
Journal:  Eur J Nucl Med       Date:  1990

5.  Indium-111-labeled autologous leukocytes in man.

Authors:  M L Thakur; J P Lavender; R N Arnot; D J Silvester; A W Segal
Journal:  J Nucl Med       Date:  1977-10       Impact factor: 10.057

6.  The development of a clinical protocol for the radiolabelling of mixed leucocytes with 99Tcm-hexamethylpropyleneamine oxime.

Authors:  H J Danpure; S Osman; M J Carroll
Journal:  Nucl Med Commun       Date:  1988-06       Impact factor: 1.690

7.  The complementary role of indium-111 labeled leukocyte imaging, ultrasonography and computed tomography in the evaluation of postoperative infection or abscess.

Authors:  K Uno; K Imazeki; N Arimizu; T Ryu; K Isono; Y Kitakata; H Kohen; S Uematsu
Journal:  Ann Nucl Med       Date:  1987-09       Impact factor: 2.668

8.  Technetium-99m HM-PAO-labeled leukocytes in detection of inflammatory lesions: comparison with gallium-67 citrate.

Authors:  M Vorne; I Soini; T Lantto; S Paakkinen
Journal:  J Nucl Med       Date:  1989-08       Impact factor: 10.057

9.  A rapid method for the preparation of 99Tcm hexametazime-labelled leucocytes.

Authors:  K K Solanki; S J Mather; M A Janabi; K E Britton
Journal:  Nucl Med Commun       Date:  1988-10       Impact factor: 1.690

10.  In vivo kinetics of canine leukocytes labeled with technetium-99m HM-PAO and indium-111 tropolonate.

Authors:  B H Mock; D S Schauwecker; D English; K A Young; H N Wellman
Journal:  J Nucl Med       Date:  1988-07       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.